시장보고서
상품코드
1671839

세계의 속용정 시장 : 유형별, 적응증별, 제형별, 연령층별, 유통 채널별, 지역별

Fast Melt Tablets Market, By Type, By Indication, By Dosage Form, By Age Group, By Distribution Channel, By Geography

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 속용정 시장은 2025년 62억 달러로 추정되고, 2032년에는 114억 1,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 CAGR 9.1%로 확대될 것으로 추정됩니다.

보고 범위 보고서 세부정보
기준연도 2024년 2025년 시장 규모 62억 달러
실적 데이터 2020-2024년 예측 기간 2025-2032년
예측 기간: 2025-2032년 CAGR: 9.10% 2032년 가치 예측 114억 1,000만 달러
그림. 속용정 시장 점유율(%), 지역별, 2025년
Fast Melt Tablets Market-IMG1

속용정이란, 씹거나 물을 필요로 하지 않고 구강내에서 순간적으로 붕괴·용해하는 구강내 붕괴정을 가리킵니다. 구강 내에서 신속하게 붕괴되거나 용해되도록 최적으로 설계되어 삼키기가 쉬워집니다. 속용정은 일반적으로 소아, 노인, 삼키는 장애가 있는 환자 등 기존의 정제나 캡슐을 삼키기가 어려운 환자를 대상으로 합니다. 속용정은 협강내에서 약제가 용해·방출되도록 설계되어 있기 때문에 삼키기를 위해 물을 필요로 하지 않습니다. 이 기술은 삼키는 기능이 저하된 환자에게 투여를 용이하게 하고 환자의 컴플라이언스를 향상시킵니다.

시장 역학:

세계의 속용정 시장은 기존의 정제나 캡슐의 삼키기가 어려운 노인 인구 증가가 견인하고 있습니다. 주요 억제요인은 기존 정제와 비교하여 빠른 용정 제조 비용이 높다는 것입니다. 그러나, 환자의 컴플라이언스가 향상되고, 특히 소아 및 노년 환자에게 투여가 간편해지는 등의 이점이 있기 때문에 예측 기간 중에 시장 성장의 유리한 기회가 초래될 것으로 기대되고 있습니다.

본 조사의 주요 특징

본 보고서에서는 세계의 속용정 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모 및 복합연간 성장률(CAGR%)을 나타냅니다.

또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.

또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.

엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 업적, 전략 등의 매개변수를 기반으로 세계 속용정 시장의 주요 기업을 프로파일링합니다.

본 조사의 대상이 되는 주요 기업은 Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Mylan NV, Amgen Inc., Allergan plhar, Aurobindo Pharma ries Ltd., Strides Pharma Science Limited, and Zydus Cadila 등이 포함됩니다.

이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.

이 세계의 속용정 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.

이해관계자들은 세계의 속용정 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 전망

  • 보고서 설명
    • 시장 정의와 범위
  • 주요 요약

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
  • 드라이버
  • 억제요인
  • 기회
  • 영향 분석
  • 주요 발전
  • 규제 시나리오
  • 제품 출시/승인
  • PEST 분석
  • PORTER 분석
  • 합병과 인수 시나리오
  • 업계 동향

제4장 세계의 속용정 시장, 유형별, 2020-2032년,(10억 달러)

  • 항정신병약
  • 항 간질약
  • 중추 신경 자극제
  • 항불안제
  • 안티파킨슨병약
  • 항 고혈압약
  • NSAIDs
  • 항 알레르기약
  • 양성자 펌프 억제제
  • 기타

제5장 세계의 속용정 시장, 적응증별, 2020-2032년,(10억 달러)

  • 통증 관리
  • 알레르기 및 호흡기 질환
  • 신경질환
  • 위장 장애
  • 심혈관 질환
  • 기타

제6장 세계의 속용정 시장, 제형별, 2020-2032년,(10억 달러)

  • 경구
  • 설하 투여
  • 구강내 투여
  • 츄어블

제7장 세계의 속용정 시장, 연령층별, 2020-2032년,(10억 달러)

  • 성인
  • 소아
  • 고령

제8장 세계의 속용정 시장, 유통 채널별, 2020-2032년,(10억 달러)

  • 병원 약국
  • 소매 약국
  • 온라인 약국

제9장 세계의 속용정 시장, 지역별, 2020-2032년, 가치(10억 달러)

  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카
    • 북아프리카
    • 중앙 아프리카

제10장 경쟁 구도

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Amgen Inc.
  • Allergan plc
  • Aurobindo Pharma Ltd.
  • Hikma Pharmaceuticals plc
  • Sun Pharmaceutical Industries Ltd.
  • Strides Pharma Science Limited
  • Zydus Cadila

제11장 분석가 추천

  • 운명의 원
  • 애널리스트의 견해
  • 일관된 기회 맵

제12장 참고문헌과 조사방법

  • 참고문헌
  • 조사 방법
  • 출판사에 대해
JHS 25.03.24

The Global Fast Melt Tablets Market is estimated to be valued at USD 6.20 Bn in 2025 and is expected to reach USD 11.41 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.20 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.10% 2032 Value Projection: USD 11.41 Bn
Figure. Fast Melt Tablets Market Share (%), By Region, 2025
Fast Melt Tablets Market - IMG1

Fast melt tablets refer to orally disintegrating tablets that disintegrate or dissolve instantaneously in the oral cavity without chewing or the need of water. They are optimally designed to rapidly disintegrate or dissolve in the mouth, thereby facilitating swallowing. Fast melt tablets generally target patients who experience difficulties in swallowing conventional tablets and capsules such as pediatric, geriatric patients, and those with dysphagia. Rapidly dissolving tablets are designed to dissolve and release the drugs in buccal cavity eliminating the need of water for swallowing. This technology offers ease of administration to patients with impaired ability to swallow and enhances patient compliance.

Market Dynamics:

The global fast melt tablets market is driven by growing geriatric population who experience difficulty in swallowing conventional tablets and capsules. The key restraining factor includes high cost of manufacturing fast melt tablets as compared to conventional tablets. However, advantages such as enhanced patient compliance and convenience of administration especially for pediatric and geriatric patients is expected to provide lucrative opportunities for market growth over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global fast melt tablets market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fast melt tablets market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Amgen Inc., Allergan plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Sun Pharmaceutical Industries Ltd., Strides Pharma Science Limited, and Zydus Cadila

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fast melt tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fast melt tablets market

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Anti Psychotics
    • Anti Epileptics
    • CNS Stimulants
    • Anxiolytics
    • Anti Parkinsonian Drugs
    • Anti Hypertensive
    • NSAIDs
    • Anti Allergy Drugs
    • Proton Pump Inhibitors
    • Others
  • Indication Insights (Revenue, USD Bn, 2020 - 2032)
    • Pain Management
    • Allergy and Respiratory Disorders
    • Neurological Disorders
    • Gastrointestinal Disorders
    • Cardiovascular Disorders
    • Others
  • Dosage Form Insights (Revenue, USD Bn, 2020 - 2032)
    • Oral
    • Sublingual
    • Buccal
    • Chewable
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Adult
    • Pediatrics
    • Geriatrics
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Novartis AG
    • Sanofi S.A.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Amgen Inc.
    • Allergan plc
    • Aurobindo Pharma Ltd.
    • Hikma Pharmaceuticals plc
    • Sun Pharmaceutical Industries Ltd.
    • Strides Pharma Science Limited
    • Zydus Cadila

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Fast Melt Tablets Market, By Type
    • Global Fast Melt Tablets Market, By Indication
    • Global Fast Melt Tablets Market, By Dosage Form
    • Global Fast Melt Tablets Market, By Age Group
    • Global Fast Melt Tablets Market, By Distribution Channel
    • Global Fast Melt Tablets Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Fast Melt Tablets Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Anti Psychotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Epileptics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • CNS Stimulants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anxiolytics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Parkinsonian Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Hypertensive
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • NSAIDs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Allergy Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Proton Pump Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Fast Melt Tablets Market, By Indication, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Allergy and Respiratory Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gastrointestinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiovascular Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Fast Melt Tablets Market, By Dosage Form, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sublingual
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Buccal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chewable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Fast Melt Tablets Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Fast Melt Tablets Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Fast Melt Tablets Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Amgen Inc.
  • Allergan plc
  • Aurobindo Pharma Ltd.
  • Hikma Pharmaceuticals plc
  • Sun Pharmaceutical Industries Ltd.
  • Strides Pharma Science Limited
  • Zydus Cadila

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제